Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-05

Clinical Trial Update: PRISM Neurofeedback Training for MDD Anhedonic Patients [NA]

View source ↗

Summary

The clinical trial evaluating PRISM neurofeedback training for patients with major depressive disorder and anhedonia has completed; sponsor GrayMatters Health L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GrayMatters Health Ltd. | Conditions: Depression, Anhedonia | NA | Status: COMPLETED